Eder Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Eder Therapeutics General Information

Description

Developer of biopharmaceutical therapies intended for addressing rare diseases and unmet medical needs. The company's platform focuses on developing gene therapies and identifying novel therapeutic targets using genomic approaches such as whole exome sequencing, integrating research partnerships, clinical development, and market access strategies, and building a patient-centric healthcare ecosystem with connections among providers, researchers, and stakeholders, enabling healthcare and life sciences markets to advance treatment availability and improve outcomes for rare disease patients.

Contact Information

Website
www.edertx.ca
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Saguenay, Quebec
  • Canada
Primary Industry
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Saguenay, Quebec
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eder Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 25-Nov-2025 Completed Pre-Clinical Trials
To view Eder Therapeutics’s complete valuation and funding history, request access »

Eder Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Capital BioVentures Accelerator/Incubator
To view Eder Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Eder Therapeutics FAQs

  • When was Eder Therapeutics founded?

    Eder Therapeutics was founded in 2023.

  • Where is Eder Therapeutics headquartered?

    Eder Therapeutics is headquartered in Saguenay, Canada.

  • What industry is Eder Therapeutics in?

    Eder Therapeutics’s primary industry is Biotechnology.

  • Is Eder Therapeutics a private or public company?

    Eder Therapeutics is a Private company.

  • What is Eder Therapeutics’s current revenue?

    The current revenue for Eder Therapeutics is .

  • Who are Eder Therapeutics’s investors?

    Capital BioVentures has invested in Eder Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process